Zhiyu B. Li
No. 150 Jimo Rd
Shanghai, 200120, China
Shanghai, 200120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 205 publications
Evolving Strategies for Previously Drugged Therapeutic Targets: Medicinal Chemistry Insights from Paradigmatic Cases.
Journal: Journal of medicinal chemistry
Published: June 02, 2026
Discovery of YYSW001: A Highly Selective, Orally Bioavailable JAK1 Inhibitor Achieving Efficacy under a Moderate-Inhibition Strategy with Improved Preclinical Tolerability.
Journal: Journal of medicinal chemistry
Published: March 20, 2026
Wogonin-derived chemotype enables discovery of novel GLS1 inhibitors with potent antitumor activity.
Wogonin-derived chemotype enables discovery of novel GLS1 inhibitors with potent antitumor activity.
Journal: Future medicinal chemistry
Published: March 12, 2026
Transvaginal ultrasonographic characteristics of different types of residual pregnancy tissue in patients with incomplete medication abortion.
Journal: Archives of gynecology and obstetrics
Published: February 24, 2026
Selective Targeting of STAT6: Recent Advances and Future Perspectives.
Journal: Medicinal research reviews
Published: January 18, 2026
The application prospects of amino acid deprivation for cancer therapy.
Journal: European journal of medicinal chemistry
Published: December 24, 2025
Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC.
Journal: Journal of virology
Published: December 09, 2025
New Binding Sites for JAK2 Inhibition in Myeloproliferative Neoplasms: Structural Insights, Therapeutic Potential, and Future Directions.
Journal: ChemMedChem
Published: November 26, 2025
Next-generation drug conjugates for breast cancer: Clinical prospects and mechanism-based strategies to overcome resistance.
Journal: Drug discovery today
Published: October 30, 2025
Design, synthesis, and pharmacological evaluation of novel isoindoline-based HPK1 degraders.
Journal: European journal of medicinal chemistry
Published: October 01, 2025
Discovery of Tricyclic Derivative as Novel and Potent Respiratory Syncytial Virus Fusion Glycoprotein Inhibitor with an Improved Pharmacokinetic Profile.
Journal: Journal of medicinal chemistry
Published: September 11, 2025
Last Updated: 09/26/2026